Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation

NCT ID: NCT00842062

Last Updated: 2015-03-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

380 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-02-28

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective, non-randomized study to evaluate the performance of the MyoScience Tissue Remodeling Device for the treatment of glabellar lines (frown lines), lateral orbital lines (crow's feet), and frontalis lines (horizontal forehead lines).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Facial Rhytides

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MyoScience Tissue Remodeling Device

Group Type EXPERIMENTAL

MyoScience Tissue Remodeling Device

Intervention Type DEVICE

Percutaneous treatment with the MyoScience device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MyoScience Tissue Remodeling Device

Percutaneous treatment with the MyoScience device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The subject must be a female 30 to 70 years of age.
* The subject must have a clinical examination prior to treatment including assessment of hyperdynamic line severity.
* The subject must have a wrinkle rating of at least "1" at rest in one or more of the following treatment areas (glabellar, lateral orbital, or frontalis).
* The subject must have signed an informed consent form.
* The subject should not have undergone any other facial cosmetic procedures at or above the level of the cheekbones within the past 6 months.
* The subject should not be participating in any other facial cosmetic research study.

Exclusion Criteria

* The subject is on a regular regimen of prescribed or over-the-counter anticoagulants.
* The subject has an infection or skin problem at the injection site.
* The subject has a history of facial nerve palsy.
* The subject has marked facial asymmetry.
* The subject has ptosis.
* The subject has excessive dermatochalasis.
* The subject has deep dermal scarring.
* The subject has thick sebaceous skin.
* The investigator is unable to substantially lessen facial lines by physical separation.
* The subject has a history of neuromuscular disorder.
* The subject has undergone prior surgery that alters the subcutaneous anatomy of the areas being treated.
* Subjects with laxity of the canthal tendon and/or with lower lid retraction, and subjects who recruit their zygomaticus major muscle to animate their crow's feet.
* The subject has any physical or psychiatric condition that in the investigator's opinion would warrant exclusion from the study or prevent the subject from completing the study.
Minimum Eligible Age

30 Years

Maximum Eligible Age

70 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pacira Pharmaceuticals, Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Aesthetics Research Center

Redwood City, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MS-3000

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Treatment of Glabellar Frown Lines
NCT02096081 COMPLETED PHASE4